Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

NCT01492972 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

192

Enrollment

NETWORK

Sponsor class

Conditions

Prostate Cancer

Interventions

RADIATION: Radiation
DRUG: Androgen Suppression Therapy

Sponsor

Proton Collaborative Group